Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05858034
Collaborator
Health Resources and Services Administration (HRSA) (U.S. Fed), National Institute on Aging (NIA) (NIH)
100
1
2
27
3.7

Study Details

Study Description

Brief Summary

The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency virus (HIV) followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinics (IDSC).

Condition or Disease Intervention/Treatment Phase
  • Other: Customized activity plan
  • Other: Customized nutrition plan
N/A

Detailed Description

The study will implement electronic medical record-based screening for frailty (eFI), further characterize frailty using comprehensive geriatric screening, and offer a customized activity and nutrition plan to a subset of participants. Participation in phlebotomy for research biomarkers of aging is optional. The study also seeks to validate the electronic medical record embedded electronic frailty index (eFI) for the prediction of adverse outcomes in aging persons with HIV, characterize the symptoms of pre-frailty and frailty in persons followed in the IDSC, and assess the acceptability and efficacy of a customized activity and nutrition intervention targeting frailty. The study will also correlate research biomarkers of aging with aging symptoms in a subset of participants.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Persons with HIV age ≥50 years followed in the Atrium Health Wake Forest Baptist Health Infectious Diseases Specialty Clinic (AHWFB IDSC), The study will take place at in the outpatient clinics of Atrium Health Wake Forest Baptist Health IDSC in Winston-Salem, NC, High Point Medical Center in High Point, NC, and Lexington Memorial Hospital (Lexington, NC).Persons with HIV age ≥50 years followed in the Atrium Health Wake Forest Baptist Health Infectious Diseases Specialty Clinic (AHWFB IDSC), The study will take place at in the outpatient clinics of Atrium Health Wake Forest Baptist Health IDSC in Winston-Salem, NC, High Point Medical Center in High Point, NC, and Lexington Memorial Hospital (Lexington, NC).
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Identifying Challenges to Healthy Aging in Persons With HIV Age 50 and Older
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Aug 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: Activity Intervention

Customized selection of exercise and other community and online activity options to improve activity.

Other: Customized activity plan
Clients with identified challenges to successful aging (pre-frail or frail on screening) will be invited to develop an individualized activity plan to increase mobility, strength, and stamina. Plans will combine activities to improve strength (resistance training), balance (balance exercises), and stamina, and establish weekly goals. Resistance bands and pedometers will be provided. Progress will be measured by self-reported adherence to the activity plan at week 2, 4, 8, 12 and 24 (assessed by telephone at weeks 2, 4, 8 and in person at week 12 and 24). Depression questionnaire (PHQ-9), fatigue screen, exhaustion questions, and SF-12, a measure of health-related quality of life, will be administered at baseline, week 12 and 24.

Other: Nutrition Intervention

Development of a customized nutrition plan to address nutritional needs.

Other: Customized nutrition plan
Participants with nutritional needs will have the option of meeting with a nutritionist to develop a personalized nutritional plan with a goal of improving diet quality and optimizing caloric intake. Progress will be measured as above.

Outcome Measures

Primary Outcome Measures

  1. Physical Performance scores [Week 12]

    Change in physical performance battery scores - Minimum score 0 - Maximum score 12 - Higher scores indicate better lower extremity function

Secondary Outcome Measures

  1. Quality of Life - 12-Item Short Form Health Survey (SF-12) Scores [Week 12]

    Change in quality of life as measured by SF-12 - Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning

  2. Percentage of Adherence with Plan [Week 12]

    Reported adherence to activity and nutrition plan

Other Outcome Measures

  1. electronic frailty index human immunodeficiency virus (eFI-HIV) scores [Baseline]

    categorized as fit (eFI ≤0.10), pre-frail (0.10 < eFI≤0.21), and frail (eFI > 0.21) - the greater the score, the increased frailty

  2. Comprehensive geriatric screening (CGS) - Short Physical Performance Battery [Week 12]

    Short performance battery score (0-12) - The SPPB total score ranges from 0 (worst performance) to 12 points (best performance) and categorically evaluates performance in the tests using three or four classes of scores: three classes: 0-6 points (poor performance), 7-9 points (moderate performance), and 10-12 points (good performance)

  3. Comprehensive geriatric screening (CGS) - Pepper Assessment Tool for Disability (PAT-D) Scores [Week 12]

    self-reported mobility, basic and instrumental activities of daily living - Responses are made on a five-point Likert scale ranging from 1 ("usually did with no difficulty") to 5 ("unable to do") or a box can be checked that reads "usually did not do for other reasons".

  4. Comprehensive geriatric screening (CGS) - brief cognitive screen (Mini-Cog) Scores [Week 12]

    (Total Possible Score: 0-5) - A total score of 0, 1, or 2 indicates higher likelihood of clinically important cognitive impairment. A total score of 3, 4, or 5 indicates lower likelihood of dementia but does not rule out some degree of cognitive impairment.

  5. depression Patient Health Questionnaire (PHQ-9) Scores [Week 12]

    Scores less than 5 almost always signified the absence of a depressive disorder; scores of 5 to 9 predominantly represented patients with either no depression or subthreshold (i.e., other) depression; scores of 10 to 14 represented a spectrum of patients; and scores of 15 or greater usually indicated major depression.

  6. anxiety questionnaire - General Anxiety Disorder-7 (GAD-7) Scores [Week 12]

    Scoring GAD-7 Anxiety Severity. This is calculated by assigning scores - GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety.

  7. fatigue/exhaustion survey scores [Week 12]

    The fatigue/exhaustion questions will be administered using a paper survey

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Person living with human immunodeficiency virus (HIV)

  • Age ≥50 years

  • Followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinic (IDSC)

  • Eligible for Ryan White Program

  • Able to provide informed consent

  • Pre-frail or frail by electronic frailty index (eFI)

Exclusion Criteria:
  • Age <50 years (study designed to characterize frailty in aging persons with HIV)

  • Unable to complete the required assessments or questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 Atrium Health Wake Forest Baptist Winston-Salem North Carolina United States 27157

Sponsors and Collaborators

  • Wake Forest University Health Sciences
  • Health Resources and Services Administration (HRSA)
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Caryn G Morse, MD, MPH, Wake Forest University Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT05858034
Other Study ID Numbers:
  • IRB00095309
  • 3P30AG021332-20
  • 6 H97HA46081-01-01
First Posted:
May 15, 2023
Last Update Posted:
May 15, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wake Forest University Health Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 15, 2023